Concepedia

Mark I. Allenby

MI

Statistics

Publications

11

Citations

613

H-Index

11

Active since

2002

Affiliations

University Hospital Southampton NHS Foundation Trust(Current)

University of Sheffield

Manchester Academic Health Science Centre

Westmead Hospital

Nottingham University Hospitals NHS Trust

Mark I. Allenby is an author at University Hospital Southampton NHS Foundation Trust specializing in cystic fibrosis, medicine, and infectious diseases.

ORCID

Publications per year

2002–2022

11

Publications

11

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

Rebecca Cosgriff, Susannah Ahern, Scott C. Bell et al. · Journal of Cystic Fibrosis · 2020 · 141 citations · Full text

, , +12

A potential role for sildenafil in the management of pulmonary hypertension in patients with parenchymal lung disease

Brendan Madden, Mark I. Allenby, Tuck-Kay Loke et al. · Vascular Pharmacology · 2006 · 118 citations

, , +7

Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5′-monophosphate in mild asthma

R.I. Ketchell, M W Jensen, Philip Lumley et al. · Journal of Allergy and Clinical Immunology · 2002 · 90 citations · Full text

, , +10

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

Elliot McClenaghan, Rebecca Cosgriff, K. Brownlee et al. · Journal of Cystic Fibrosis · 2020 · 90 citations · Full text

, , +6

Supporting medication adherence for adults with cystic fibrosis: a randomised feasibility study

Daniel Hind, Sarah J Drabble, Madelynne A Arden et al. · BMC Pulmonary Medicine · 2019 · 42 citations · Full text

, , +14

1–5 of 11